Article
PTEN deletion is rare but often homogeneous in gastric cancer.
Journal of clinical pathology - 1 Aug 2012
Mina Sormeh, Bohn Benjamin A, Simon Ronald, Krohn Antje, Reeh Matthias, Arnold Dirk, Bokemeyer Carsten, Sauter Guido, Izbicki Jakob R, Marx Andreas, Stahl Phillip R
Abstract excerpt
BACKGROUND AND AIM: Gastric carcinoma is the second most frequent cause of cancer-related death worldwide. As PTEN is a potential modifier of tumour response to trastuzumab, a recently approved therapy in metastatic HER2 positive gastric cancer, the existence of PTEN deletions in primary gastric cancer was investigated. METHODS: 230 primary gastric cancers were analysed in a tissue microarray format by dual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
